|
TSG101 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.819600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.568470E-02 |
| Normal-vs-Stage2 |
2.078400E-02 |
| Normal-vs-Stage3 |
1.299020E-03 |
| Normal-vs-Stage4 |
2.387000E-04 |
| Stage1-vs-Stage2 |
6.300000E-01 |
| Stage1-vs-Stage3 |
7.932200E-02 |
| Stage1-vs-Stage4 |
4.725700E-02 |
| Stage2-vs-Stage3 |
4.687000E-01 |
| Stage2-vs-Stage4 |
2.337200E-01 |
| Stage3-vs-Stage4 |
6.129200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.041000E-03 |
| Normal-vs-AfricanAmerican |
5.011600E-01 |
| Normal-vs-Asian |
1.048060E-02 |
| Caucasian-vs-AfricanAmerican |
1.518010E-01 |
| Caucasian-vs-Asian |
9.943600E-01 |
| AfricanAmerican-vs-Asian |
1.958040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.064970E-03 |
| Normal-vs-Female |
6.843600E-03 |
| Male-vs-Female |
1.792620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.764300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.901900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.755700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.337700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.587400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.555900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.503000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.212800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.009400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.364600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.717200E-01 |
| Classical-VS-Follicular |
5.956400E-01 |
| Classical-VS-Other |
4.568400E-01 |
| Classical-VS-Normal |
5.820300E-03 |
| Tall-VS-Follicular |
9.866200E-01 |
| Tall-VS-Other |
6.541600E-01 |
| Tall-VS-Normal |
2.914400E-02 |
| Follicular-VS-Other |
7.140600E-01 |
| Follicular-VS-Normal |
1.331860E-02 |
| Other-VS-Normal |
8.066200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.063580E-03 |
| Normal-vs-N1 |
1.442020E-04 |
| N0-vs-N1 |
1.061650E-01 |
|
|
